Table 3.
Results of the univariate analysis between tumor budding and overall survival.
| Variable | Statistics | HR (95% CI) | p-value |
|---|---|---|---|
| TB location, n (%) | |||
| No | 58 (44.62) | 1.0 | |
| PTB | 10 (7.69) | 2.37 (1.08–5.19) | 0.03 |
| ITB | 11 (8.46) | 1.57 (0.69–3.60) | 0.28 |
| TTB | 51 (39.23) | 2.02 (1.25–3.28) | 0.004 |
| PTB count, n (median, range) | 0 (0–43) | 1.03 (1.01–1.05) | 0.01 |
| PTB, n (%) | |||
| No | 69 (53.08) | 1.0 | |
| Yes | 61 (46.92) | 1.93 (1.25–2.99) | 0.003 |
| PTB, n (%) | |||
| <5 | 74 (56.92) | 1.0 | |
| ≥5 | 56 (43.08) | 1.95 (1.26–3.02) | 0.003 |
| PTB, n (%) | |||
| <10 | 97 (74.62) | 1.0 | |
| ≥10 | 33 (25.38) | 1.85 (1.15–2.97) | 0.01 |
| ITB count, n (median, range) | 0 (0–41) | 1.03 (1.01–1.05) | 0.01 |
| ITB, n (%) | |||
| No | 68 (52.31) | 1.0 | |
| Yes | 62 (47.69) | 1.69 (1.09–2.62) | 0.02 |
| ITB, n (%) | |||
| <5 | 78 (60.00) | 1.0 | |
| ≥5 | 52 (40.00) | 1.73 (1.12–2.69) | 0.01 |
| ITB, n (%) | |||
| <10 | 97 (74.62) | 1.0 | |
| ≥10 | 33 (25.38) | 2.00 (1.24–3.22) | 0.005 |
| TTB count, n (median, range) | 5.5 (0–72) | 1.02 (1.01–1.03) | 0.005 |
| TTB, n (%) | |||
| No | 58 (44.62) | 1.0 | |
| Yes | 72 (55.38) | 1.99 (1.26–3.13) | 0.003 |
| TTB, n (%) | |||
| <5 | 65 (50.00) | 1.0 | |
| ≥5 | 65 (50.00) | 1.89 (1.21–2.94) | 0.005 |
| TTB, n (%) | |||
| <10 | 70 (53.85) | 1.0 | |
| ≥10 | 60 (46.15) | 1.82 (1.17–2.81) | 0.007 |
| TB score | 0.49 (0.00-1.08) | 2.71 (1.48–4.96) | 0.0012 |
| TB score, n (%) | |||
| TB score-low group | 84 (64.62) | 1.0 | |
| TB score-high group | 46 (35.38) | 2.28 (1.46–3.54) | 0.0003 |
HR, hazard ratio; CI, confidence interval; TB, tumor budding; PTB, peritumoral budding; ITB, intratumoral budding; TTB, total tumor budding (PTB+ITB).